Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.

Hangai M, Urayama KY, Tanaka J, Kato K, Nishiwaki S, Koh K, Noguchi M, Kato K, Yoshida N, Sato M, Goto H, Yuza Y, Hashii Y, Atsuta Y, Mizuta S, Kato M.

Biol Blood Marrow Transplant. 2019 Apr 17. pii: S1083-8791(19)30237-X. doi: 10.1016/j.bbmt.2019.04.014. [Epub ahead of print]

PMID:
31002992
2.

Allogeneic Hematopoietic Stem Cell Transplantation for Adolescents and Young Adults with Acute Myeloid Leukemia.

Tomizawa D, Tanaka S, Kondo T, Hashii Y, Arai Y, Kudo K, Taga T, Fukuda T, Goto H, Inagaki J, Koh K, Ohashi K, Ozawa Y, Inoue M, Kato K, Tanaka J, Atsuta Y, Adachi S, Ishida H.

Biol Blood Marrow Transplant. 2017 Sep;23(9):1515-1522. doi: 10.1016/j.bbmt.2017.05.009. Epub 2017 May 10.

3.

Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.

Burke MJ, Gossai N, Wagner JE, Smith AR, Bachanova V, Cao Q, MacMillan ML, Stefanski HS, Weisdorf DJ, Verneris MR.

Biol Blood Marrow Transplant. 2013 Jan;19(1):138-42. doi: 10.1016/j.bbmt.2012.08.020. Epub 2012 Sep 6.

4.

[Retrospective Analysis of the Impact of Treatment on Prognosis in 44 Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia].

Chen XP, Lv N, Li YH, Jing Y, Yu L.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Feb;24(1):14-8. doi: 10.7534/j.issn.1009-2137.2016.01.003. Chinese.

PMID:
26913386
5.

Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.

Vignon M, Andreoli A, Dhédin N, Lengliné E, Masson E, Robin M, Granier C, Larghero J, Schlageter MH, de Latour RP, Socié G, Boissel N.

J Adolesc Young Adult Oncol. 2017 Jun;6(2):299-306. doi: 10.1089/jayao.2016.0060. Epub 2016 Dec 16.

PMID:
27983886
6.

Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review.

Mateos MK, O'Brien TA, Oswald C, Gabriel M, Ziegler DS, Cohn RJ, Russell SJ, Barbaric D, Marshall GM, Trahair TN.

Pediatr Blood Cancer. 2013 Sep;60(9):1520-7. doi: 10.1002/pbc.24559. Epub 2013 Jun 3.

7.

Survival improvements in adolescents and young adults after myeloablative allogeneic transplantation for acute lymphoblastic leukemia.

Wood WA, Lee SJ, Brazauskas R, Wang Z, Aljurf MD, Ballen KK, Buchbinder DK, Dehn J, Freytes CO, Lazarus HM, Lemaistre CF, Mehta P, Szwajcer D, Joffe S, Majhail NS.

Biol Blood Marrow Transplant. 2014 Jun;20(6):829-36. doi: 10.1016/j.bbmt.2014.02.021. Epub 2014 Mar 7.

8.

Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.

Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T.

Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26.

9.

Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.

Kahn JM, Keegan TH, Tao L, Abrahão R, Bleyer A, Viny AD.

Cancer. 2016 Sep 1;122(17):2723-30. doi: 10.1002/cncr.30089. Epub 2016 Jun 10.

10.

Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia.

Majhail NS, Brazauskas R, Hassebroek A, Bredeson CN, Hahn T, Hale GA, Horowitz MM, Lazarus HM, Maziarz RT, Wood WA, Parsons SK, Joffe S, Rizzo JD, Lee SJ, Hayes-Lattin BM.

Biol Blood Marrow Transplant. 2012 Jun;18(6):861-73. doi: 10.1016/j.bbmt.2011.10.031. Epub 2011 Oct 29.

11.

Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China.

Ding Z, Han MZ, Chen SL, Ma QL, Wei JL, Pang AM, Zhang XY, Liang C, Yao JF, Cao YG, Feng SZ, Jiang EL.

Chin Med J (Engl). 2015 Aug 5;128(15):2065-71. doi: 10.4103/0366-6999.161365.

12.

Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia: A National Population-Based Cohort Study.

Østgård LSG, Lund JL, Nørgaard JM, Nørgaard M, Medeiros BC, Nielsen B, Nielsen OJ, Overgaard UM, Kallenbach M, Marcher CW, Riis AH, Sengeløv H.

Biol Blood Marrow Transplant. 2018 Feb;24(2):314-323. doi: 10.1016/j.bbmt.2017.10.019. Epub 2017 Oct 16.

13.

Patterns of care and outcomes in adolescent and young adult acute lymphoblastic leukemia: a population-based study.

Muffly L, Alvarez E, Lichtensztajn D, Abrahão R, Gomez SL, Keegan T.

Blood Adv. 2018 Apr 24;2(8):895-903. doi: 10.1182/bloodadvances.2017014944.

14.

The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study.

Gupta S, Pole JD, Baxter NN, Sutradhar R, Lau C, Nagamuthu C, Nathan PC.

Cancer Med. 2019 Mar 26. doi: 10.1002/cam4.2096. [Epub ahead of print]

15.

Malignant lymphoma of adolescents and young adults: from the viewpoint of pediatricians.

Kobayashi R, Sekimizu M.

Rinsho Ketsueki. 2017;58(8):1053-1059. doi: 10.11406/rinketsu.58.1053. Japanese.

PMID:
28883269
16.

Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes.

Dalle JH, Balduzzi A, Bader P, Lankester A, Yaniv I, Wachowiak J, Pieczonka A, Bierings M, Yesilipek A, Sedlaçek P, Ifversen M, Sufliarska S, Toporski J, Glogova E, Poetschger U, Peters C.

Biol Blood Marrow Transplant. 2018 Sep;24(9):1848-1855. doi: 10.1016/j.bbmt.2018.05.009. Epub 2018 May 14.

PMID:
29772352
17.

Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groups.

Mo XD, Xu LP, Zhang XH, Liu DH, Wang Y, Chen H, Yan CH, Chen YH, Han W, Wang FR, Wang JZ, Liu KY, Huang XJ.

Int J Cancer. 2015 Apr 1;136(7):1697-707. doi: 10.1002/ijc.29146. Epub 2014 Sep 2.

18.

Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.

Muffly L, Lichtensztajn D, Shiraz P, Abrahão R, McNeer J, Stock W, Keegan T, Gomez SL.

Cancer. 2017 Jan 1;123(1):122-130. doi: 10.1002/cncr.30322. Epub 2016 Sep 13.

19.

Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Leukemia.

Inagaki J, Noguchi M, Kurauchi K, Tanioka S, Fukano R, Okamura J.

Biol Blood Marrow Transplant. 2016 Feb;22(2):300-306. doi: 10.1016/j.bbmt.2015.09.006. Epub 2015 Sep 11.

20.

Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era.

Xue YJ, Cheng YF, Lu AD, Wang Y, Zuo YX, Yan CH, Wu J, Sun YQ, Suo P, Chen YH, Chen H, Jia YP, Liu KY, Han W, Xu LP, Zhang LP, Huang XJ.

Biol Blood Marrow Transplant. 2018 Dec 8. pii: S1083-8791(18)30806-1. doi: 10.1016/j.bbmt.2018.12.007. [Epub ahead of print]

PMID:
30537550

Supplemental Content

Support Center